Guaranteed performance of individual control chart used in gamma passing rate-based patient-specific quality assurance. (May 2023)
- Record Type:
- Journal Article
- Title:
- Guaranteed performance of individual control chart used in gamma passing rate-based patient-specific quality assurance. (May 2023)
- Main Title:
- Guaranteed performance of individual control chart used in gamma passing rate-based patient-specific quality assurance
- Authors:
- Li, Guangjun
Xiao, Qing
Dai, Guyu
Wang, Qiang
Bai, Long
Zhang, Xiangbin
Zhang, Xiangyu
Duan, Lian
Zhong, Renming
Bai, Sen - Abstract:
- Highlights: The sampling variability seriously affects the performance of PSQA tolerance limits. The smaller the sample, the higher the risk of tolerance limits for clinical use. Out-of-control values must be identified and eliminated before calculating the limits. The WSD method exhibits sufficient robustness and reliability for unknown PSQAs. Abstract: Purpose: To assess the effect of sampling variability on the performance of individual charts (I-charts) for PSQA and provide a robust and reliable method for unknown PSQA processes. Materials and methods: A total of 1327 pretreatment PSQAs were analyzed. Different datasets with samples in the range of 20–1000 were used to estimate the lower control limit (LCL). Based on the iterative "Identify-Eliminate-Recalculate" and direct calculation without any outlier filtering procedures, five I-charts methods, namely the Shewhart, quantile, scaled weighted variance (SWV), weighted standard deviation (WSD), and skewness correction (SC) method, were used to compute the LCL. The average run length (ARL0 ) and false alarm rate (FAR0 ) were calculated to evaluate the performance of LCL. Results: The ground truth of the values of LCL, FAR0, and ARL0 obtained via in-control PSQAs were 92.31%, 0.135%, and 740.7, respectively. Further, for in-control PSQAs, the width of the 95% confidence interval of LCL values for all methods tended to decrease with the increase in sample size. In all sample ranges of in-control PSQAs, only the median LCLHighlights: The sampling variability seriously affects the performance of PSQA tolerance limits. The smaller the sample, the higher the risk of tolerance limits for clinical use. Out-of-control values must be identified and eliminated before calculating the limits. The WSD method exhibits sufficient robustness and reliability for unknown PSQAs. Abstract: Purpose: To assess the effect of sampling variability on the performance of individual charts (I-charts) for PSQA and provide a robust and reliable method for unknown PSQA processes. Materials and methods: A total of 1327 pretreatment PSQAs were analyzed. Different datasets with samples in the range of 20–1000 were used to estimate the lower control limit (LCL). Based on the iterative "Identify-Eliminate-Recalculate" and direct calculation without any outlier filtering procedures, five I-charts methods, namely the Shewhart, quantile, scaled weighted variance (SWV), weighted standard deviation (WSD), and skewness correction (SC) method, were used to compute the LCL. The average run length (ARL0 ) and false alarm rate (FAR0 ) were calculated to evaluate the performance of LCL. Results: The ground truth of the values of LCL, FAR0, and ARL0 obtained via in-control PSQAs were 92.31%, 0.135%, and 740.7, respectively. Further, for in-control PSQAs, the width of the 95% confidence interval of LCL values for all methods tended to decrease with the increase in sample size. In all sample ranges of in-control PSQAs, only the median LCL and ARL0 values obtained via WSD and SWV methods were close to the ground truth. For the actual unknown PSQAs, based on the "Identify-Eliminate-Recalculate" procedure, only the median LCL values obtained by the WSD method were closest to the ground truth. Conclusions: Sampling variability seriously affected the I-chart performance in PSQA processes, particularly for small samples. For unknown PSQAs, the WSD method based on the implementation of the iterative "Identify-Eliminate-Recalculate" procedure exhibited sufficient robustness and reliability. … (more)
- Is Part Of:
- Physica medica. Volume 109(2023)
- Journal:
- Physica medica
- Issue:
- Volume 109(2023)
- Issue Display:
- Volume 109, Issue 2023 (2023)
- Year:
- 2023
- Volume:
- 109
- Issue:
- 2023
- Issue Sort Value:
- 2023-0109-2023-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-05
- Subjects:
- Patient-specific quality assurance -- Statistical process control -- Gamma passing rate -- Individual control chart -- Sample size -- Sampling variability
Medical physics -- Periodicals
Biophysics -- Periodicals
Biophysics -- Periodicals
Imagerie médicale -- Périodiques
Radiothérapie -- Périodiques
Rayons X -- Sécurité -- Mesures -- Périodiques
Physique -- Périodiques
Médecine -- Périodiques
610.153 - Journal URLs:
- http://www.sciencedirect.com/science/journal/11201797 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/11201797 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/11201797 ↗
http://www.elsevier.com/journals ↗
http://www.physicamedica.com ↗ - DOI:
- 10.1016/j.ejmp.2023.102581 ↗
- Languages:
- English
- ISSNs:
- 1120-1797
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6475.070000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 27028.xml